Latest rheumatism Stories
EAST BRUNSWICK, N.J., April 28, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that three abstracts will be presented at the European League Against Rheumatism (EULAR) 2011 Annual Congress.
Includes discussion of key development activities in the rheumatology pipeline, perspectives on unmet needs and how different mechanisms are likely to address them, and updates on most promising compounds in development. Scottsdale, AZ (PRWEB) April 20, 2011 MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies with a stake in the market for rheumatology...
We are dedicated to the diagnosis and treatment of people with arthritis and related autoimmune diseases. Appropriate, early treatment helps to preserve function and mobility, relieve or control pain, and improve the ability to perform activities of daily living.
A serendipitous discovery by academics at The University of Nottingham has shown that a simple illusion can significantly reduce â€” and in some cases even temporarily eradicate â€” arthritic pain in the hand.
CHAPEL HILL, N.C., March 16, 2011 /PRNewswire/ -- TSI Healthcare, a national leader in adoption focused healthcare technology solutions, today announced its partnership with The Center for Arthritis and Rheumatic Diseases in San Antonio, Texas.
The Spondylitis Association of America's (SAA) online Screening Tool for Ankylosing Spondylitis was featured in a news story on ABCNews.com on March 8.
Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma.
A recent trial of rituximab in combination with a tumor necrosis factor (TNF) inhibitor and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) found the safety profile to be consistent with other RA trials with TNF inhibitors.
ATLANTA and PORTLAND, Ore., March 2, 2011 /PRNewswire-USNewswire/ -- Two leading patient advocacy organizations have joined forces to educate people about psoriatic arthritis, an inflammatory disease that can lead to joint damage, especially if not diagnosed and treated early.
THOUSAND OAKS, Calif.
- A serpent whose bite was fabled to produce intense thirst.